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From the affinity labelling of 70 S ribosomes with a photoreactive d rivative of Phe-tRNAPhe b aring an 
arylazido group on guanine residues, it has been found that different sets of ribosomal proteins are labelled 
in the course of three successive steps of EF-Tu-dependent binding of aminoacyl-tRNA derivative at the 
A-site. Proteins S.5, S7, S8, S16, S17, L9, L14, L15 and L24 were Iabelled before GTP hydrolysis; proteins 
S5, S7. S9, Sll, S14. S18, S19, S21, L9, L21 and L29 - after GTP hydrolysis: proteins S2, S5, S7, S21, Lll 
and L23 - after GTP hydrolysis and transpeptidation. 
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1. INTRODUCTION 
The factor-dependent binding of aminoacyl- 
tRNA at the ribosomal A-site is a rather com- 
plicated process and includes at least two steps. In- 
deed, it was repeatedly noted that aminoacyl- 
tRNA being bound at the A-site behaved different- 
ly before and after GTP hydrolysis. If Phe-tRNA 
was bound in the presence of EF-Tu and 
GMPPCP (non-cleavable analogue of GTP), Ac- 
Phe-tRNAPhe, located at the P-site, was able to 
react with puromycin. When GMPPCP was 
substituted for GTP, Ac-Phe-puromycin was not 
formed, but Phe-tRNAPhe was competent in Ac- 
Phe-Phe-tRNAPhe synthesis [l-6]. Hamburger et 
al. [7] compared thermostabilities of the A-site 
complexes of Phe-tRNAPh’ with ribosomes and 
found the complex produced with EF-Tu and GTP 
to be more stable than that formed in the presence 
of EF-Tu and GMPPCP. Yokosawa et al. [5] 
showed that labelled aminoacyl-tRNA bound at 
the A-site in the presence of EF-Tu and GMPPCP 
was able to exchange for the unlabelled species, 
whereas the exchange could not be detected if the 
binding was carried out in the presence of EF-Tu 
and GTP. In the system where the P-site was 
preoccupied by Ac-Phe-tRNAoP;hp,,d, an analogue of 
peptidyl-tRNA without donor activity (i.e., the 
binding of aminoacyl-tRNA and peptide bond syn- 
thesis were uncoupled), the factor-dependent bind- 
ing of Phe-tRNAPh’ was found to be much more 
stable than the factor-free one [8,9]. 
Here, we have studied the arrangement of 
aminoacyl-tRNA in the course of 3 well 
distinguishable steps of its interaction with the A- 
site of 70 S ribosomes: 
(i) Before GTP hydrolysis and removal of EF-Tu 
from ribosomes (the P-site was preoccupied by Ac- 
Phe-tRNAPhe; the binding of Phe-tRNAPhe was 
carried out in the presence of EF-Tu and 
GMPPCP); 
(ii) After GTP hydrolysis but before transpeptida- 
tion (Ac-Phe-tRNxzed at the P-site; the binding 
of Phe-tRNAPhe - in the presence of EF-Tu and 
GTP); 
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(iii) After both GTP hydrolysis and transpeptida- 
tion (AC-Phe-tRNAPhe at the P-site; the binding of 
Phe-tRNAPhe - in the presence of EF-Tu and 
GTP). 
For the modification of ribosomal components 
to occur, Phe-tRNAPhe was substituted for its 
photoactivated derivative, Phe-azido-tRNAPhe, 
bearing arylazido groups scattered statistically 
over tRNA guanosine residues [ 10-121. The 
ribosomal 16 S and 23 S RNAs were not modified 
after UV irradiation, but the sets of ribosomal pro- 
teins cross-linked to tRNA were found to differ 
drastically in all 3 model complexes described 
above. 
2. MATERIALS AND METHODS 
Active 30 S and 50 S ribosomal subunits were 
isolated from E. coli MRE-600 as in [ 131. Enriched 
preparations of [14C]Phe-tRNAPhe (1400 pmol/ 
A260 unit), Ac-[14C]Phe-tRNAPhe (1400 pmol/Azho 
unit), Ac-[14C]Phe-tRNA&d (1250 pmol/Azeo 
unit) and tRNAPhe (1400 pmol/Azeo unit) were 
prepared as in [9,13]. 14C-labelled 4-(N-2-chloro- 
ethyl-N-methylamino)benzylamine (25 mCi/mmol) 
was synthesized as in [14,15]. 2,4- Dinitro-5-fluor- 
ophenylazide was prepared according to [ 161. 
Elongation factors Tu .Ts and G were isolated by 
the procedure of Arai et al. [17]. Free EF-Tu was 
obtained as in [6] and its activity was tested as in 
[ 181. Azido-[r4C]tRNAPh’ was prepared as in [lo]; 
the extent of modification with arylazido groups 
was determined to be 3 mol reagent residues/m01 
tRNAPhe. Aminoacylation of both unmodified 
tRNAPhe and azido-[‘4C]tRNAPh’ was performed 
as in [12]. Ribosomal complex I, containing Ac- 
Phe-tRNAPhe at the P-site and Phe-azido-tRNAPh’ 
at the A-site (bound in the presence of EF-Tu and 
GMPPCP), was formed by mixing two inter- 
mediate complexes 1 and 3 (see table 1). Complex 
II, where GTP hydrolysis was allowed to occur but 
transpeptidation was prevented by substitution of 
Ac-Phe-tRNAPhe (at the P-site) for its analogue 
without donor activity (Ac-Phe- tRNA,P,l’,,d), was 
obtained by mixing intermediate complexes 2 and 
4. Complex III, where both GTP hydrolysis and 
transpeptidation were permitted, was obtained by 
mixing intermediate complexes 1 and 4. Complexes 
I-III were incubated 90 min at 0°C; the final con- 
centration of Mg’+ was adjusted to 10 mM in all 
Table 1 
Composition and formation of intermediate complexes 1-4 
P-site 
complexes 
No. Components Incubation 
1 7.8 nmol 30 S subunits 
10 nmol 50 S subunits 
5 boll mg 
11.8 nmol Ac-[‘4C]Phe-tRNAPhe 90 min at 0°C 
in 3.14 ml of 
2 The same, but Ac-[i4C]Phe-tRNAPh’ buffer Ia 
was substituted for 
Ac-[‘4C]Phe-tRNA,cd 
Ternary 
complexes 
7.8 nmol Phe-azido-[‘“C]tRNAPh’ 
20 nmol EF-Tu 
12 ymol GMPPCP 
7.8 nmol Phe-azido-[‘4C]tRNAPhe 
40 nmol EF-Tu.Ts 
0.45 pmol GTP 
30 min at 0°C 
in 1.9ml of 
buffer IIb 
a Buffer I: 20 mM Tris-HCl (pH 7.4), 15 mM MgClz, 200 mM NH4Cl 
b Buffer II: 20 mM Tris-HCI (pH 7.4), 10 mM MgClz, 200 mM NH4CI 
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cases. Translocation in complex III was carried out 
as in [6]. Inhibition of the A-site binding of 
aminoacyl-tRNA by tetracycline and puromycin 
reaction were performed according to [ 191. EF-Tu- 
dependent binding of aminoacyl-tRNA with 
ribosomes was measured by centrifuging com- 
plexes through the sucrose density gradients 
lo-30% in buffer II. UV irradiation of the com- 
plexes (A 2 350 nm), separation of the ribosomes 
into subunits, isolation of ribosomal proteins and 
analysis of distribution of 14C label among them by 
two-dimensional electrophoresis in polyacrylamide 
gel were carried out as in [20]. Before the analysis 
modified tRNA covalently bound to ribosomal 
proteins was digested by RNases Ti and A and 
phosphomonoesterase. As shown earlier, the treat- 
ment produces a small oligonucleotide fragment 
covalently linked to ribosomal proteins and bear- 
ing charge 0 or - 1. These fragments practically do 
not affect electrophoretic mobilities of the proteins 
[20]. [ “C]Phenylalanine (3 18 mCi/mmol) was 
from UVVVR (Czechoslovakia), poly(U) from 
Reanal (Hungary), 5 ‘-guanylyl (&y-methylene)di- 
phosphonate (GMPPCP) from Serva (FRG), 
RNases Tr and A from Sankyo (Japan); 
phosphomonoesterase was purchased from Serva. 
3. RESULTS 
In this work we used 70 S ribosomes with fully 
active P- and A-sites for studying 3 model com- 
plexes (states) which imitated different steps of 
selection of codon-specific aminoacyl-tRNA at the 
A-site: before GTP hydrolysis (complex I; for 
details see section 2); after GTP hydrolysis but 
before transpeptidation (complex II); after both 
GTP hydrolysis and transpeptidation (complex 
III). 
The control experiments carried out with un- 
modified Phe-tRNAPh” showed that only in the 
case of EF-Tu + GMPPCP-dependent binding was 
peptidyl-tRNA located at the P-site able to react 
with puromycin (table 2). This state of aminoacyl- 
tRNA at the A-site (complex I), with the acceptor 
site of peptidyltransferase center being vacant for 
puromycin binding, is analogous to that observed 
earlier [l-4,6] and designated by Lake as a 
separate ‘R’ site [21]. 
To prove the peptide bond formation in the 
complex III carrying [‘4C]Phe-azido-[‘2C]tRNA it 
was isolated by centrifugation through 10% 
sucrose in buffer II. Then EF-G and GTP were 
added to the complex and translocation was al- 
lowed to proceed. Puromycin treatment of this 
post-translocation complex indicated that Ac-Phe- 
Phe-puromycin was synthesized in 91% complexes 
(not shown). 
The data on EF-Tu-dependent binding of Phe- 
azido-[14C]tRNAPh’ are shown in table 3. The level 
of this binding is 3-4-times lower than that of un- 
modified Phe-tRNAPhe. It can be explained readily 
if we assume that the preparation of statistically 
modified tRNAPhe contains some portion of 
molecules failing to form the ternary complex with 
EF-Tu and GTP (or GMPPCP). Nevertheless, the 
binding of a remaining active portion of Phe- 
Table 2 
Binding of [‘4C]Phe-tRNAPhe at the A-site of 70 S ribosome 
tRNA derivative at the 
P-site 
Components added to [‘4C]Phe-tRNAPhe Ac-[r4C]Phe-puro- 
[‘4C]Phe-tRNAPh’ bound, mol tRNA/ mycin formed, 
mol 70 S mol/mol 70 S 
EF-Tu GTP GMPP- Tetra- 
CP cycline 
Ac-[‘4C]Phe-tRNAPh’ 
Ac-[‘4C]Phe-tRNAPh’ 
Ac-[‘4C]Phe-tRNAPhe 
Ac-[‘4C]Phe-tRNA%d 
Ac-[‘4C]Phe-tRNAEfi&r 
Ac-[‘“C]Phe-tRNAoPxle,d 
+ + - _ 0.80 0.17 
+ + _ + 0.14 - 
+ _ + - 0.85 0.74 
+ + - - 0.81 0.00 
+ + - + 0.15 - 
+ _ - - 0.19 - 
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Table 3 
Binding and cross-linking of Phe-[‘4C]azido-tRNAPhe at the A-site of 70 S ribosome 
Complex 
(for details 
see text) 
I 
Components added to Phe- Unlabelled tRNA Azido-tRNA Azido-tRNA 
[‘4C]azido-tRNAPhe derivative at the bound, mol cross-linked, 
P-site tRNA/mol 70 S mol tRNA/mol 
EF-Tu GTP GMP- Tetra- subunit 
PCP cycline 
30 s 50 s 
+ _ + _ AcPhe-tRNAPhe 0.24 0.045 0.026 
+ _ _ _ AcPhe-tRNAPhe 0.07 
+ _ + + AcPhe-tRNAPhe 0.02 0.004 0.002 
- _ - - AcPhe-tRNAPhe 0.01 
II + + - _ AcPhe-tRNAPr!’ ox red 0.21 0.043 0.038 
+ + _ + AcPhe-tRNA$&d 0.03 0.005 0.003 
III + + - - AcPhe-tRNAPh’ 0.22 0.044 0.026 
+ + - + AcPhe-tRNAPhe 0.03 0.005 0.002 
CPm, 
cpm, 
29 
600 
Lll 21 
1 
300 
wm 
t 900 
cPm 
900 1 
protan 1‘ 
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Fig.1. Distribution of the 14C label among ribosomal 
proteins modified by Phe-azido-[‘4C]tRNAPh’ at 
different steps of its factor-dependent binding at the A 
site of 70 S ribosomes: I, complex I; II, complex II; III, 
complex III (for details see text). 
azido-[14C]tRNAPhe IS seen to be factor-dependent 
and occurs at the A-site judging by the inhibitory 
action of tetracycline (table 3). 
Complexes I, II and III carrying Phe-azido- 
[ 14C]tRNAPh’ were irradiated with UV light (h 2 
350 nm), and the distribution of 14C label among 
ribosomal subunits was analyzed by sedimentation 
through a sucrose density gradient in 0.5 mM 
Mg2+. It appeared that the amount of r4C label 
covalently bound to the 30 S subunits did not dif- 
fer in all 3 complexes. In contrast, 50 S subunits in 
the complex II were labeled 1.5fold higher than 
those in complexes I and III (table 3). Specificity of 
photocross-linking of azido-tRNA to ribosomes 
(no reaction out of the complex) was shown earlier 
[12]. Sedimentation of the complexes in the 
presence of SDS and EDTA revealed that in all 
cases only ribosomal proteins rather than 16 S and 
23 S RNAs were cross-linked to tRNA (5 S RNA 
was not tested). 
The results of the analysis of the modified pro- 
tein by two-dimensional electrophoresis in 
polyacrylamide gel (see section 2) are shown in 
fig. 1. The sets and numbers of these proteins are 
seen to be different in all complexes studied. We 
observed only two common proteins, S5 and S7. 
4. DISCUSSION 
The affinity labelling of the A-site components 
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by Phe-azido-[‘4C]tRNAPhe was studied earlier 
when the P-site had been preoccupied with 
deacylated tRNA [ 121. The set of modified pro- 
teins appeared to differ from that found in com- 
plex II in this paper. Only proteins S9, S18, S19 
and L9 are common in both cases (the spot cor- 
responding to protein L9 was erroneously iden- 
tified as LS/L9 in all our previous papers 
[IO-12,20,22] starting from [23]). One can draw 
the conclusion that the arrangement of aminoacyl- 
tRNA at the A-site depends on the ligand located 
at the P-site. When comparing the data on label- 
ling of proteins at the P- and A-sites ([11,12,22] 
and this paper), we find 7 common proteins: SS, 
S7, S9, Sll, S14, S19and S21. Hence, wecancon- 
elude that these proteins are in close vicinity to 
both sites. Proteins S5 and S7 cross-link with 
aminoacyl-tRNA derivatives at all 3 states of the 
A-site but these proteins may be labelled by tRNA 
derivatives at the P-site in some cases [22]. Accord- 
ing to Lake [21], protein S5 only participates in the 
formation of the R-site (this corresponds to the 
state, or complex I in this work). Ofengand et al. 
[24] observed that Phe-tRNAPhe with an arylazido 
group attached to the s4Us residue was able to 
cross-link at the A- rather than at the R-site, and 
concluded that different surroundings of the 
aminoacyl-tRNA exist at both sites. On the other 
hand, Kruse et al. [6] investigated photocross-links 
between Phe-tRNAPh’ and ribosomes at the R-site 
(complex I) and A-site (complex III, after GTP 
hydrolysis and transpeptidation). They found that 
cross-linking patterns for 30 S and 50 S subunits 
were nearly identical and concluded that both A- 
and R-sites are ‘similar structurally’. We also 
observe the absence of any changes in the amounts 
of 14C label cross-linked to both subunits in com- 
plexes I and III. But the sets of proteins labelled in 
A- (complex III) and R- (complex I) sites are not 
identical (see fig. l), indicating some differences in 
arrangement of the tRNA molecule in these 
complexes. 
In the literature only few data are available on 
the influence of the peptidyl moiety on the ar- 
rangement of tRNA at the A-site. Lin et al. [25] 
reported that photocross-linking of tRNAPhe 
derivatives with an arylazido group of the s41Js 
residue to protein S19 was the same when the 
derivative of Phe-tRNAPhe (situation similar to our 
complex II but with deacylated tRNA at the P-site) 
or AcPhePhe-tRNAPhe (our complex III) was 
located at the A-site. The use of azido-tRNAPhe 
allowed us to detect the differences in arrangement 
of the tRNA molecule at the A-site caused by 
transpeptidation. 
Hence, our data directly indicate the changes in 
arrangement of the tRNA molecule in the course 
of 3 steps of enzymatic binding at the A-site: 
before GTP hydrolysis, after GTP hydrolysis and 
release of EF-Tu, and after transpeptidation. 
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